Summary & Overview
CPT 95874: EMG Guidance for Chemodenervation Injection
CPT code 95874 represents an add-on procedure for needle electromyography (EMG) guidance used during chemodenervation injections, such as injections of botulinum toxin or ethyl alcohol, to target nerves supplying spastic muscles. Nationally, accurate reporting of this code matters because it documents the use of EMG guidance when administering neurotoxin injections, affecting clinical records, billing accuracy, and appropriate valuation of the technical skill involved.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise overview of clinical context for chemodenervation with EMG guidance, typical sites of service, coding relationships, and the operational implications for providers and billing teams. Readers will find benchmarks and coding practice guidance, summaries of payer coverage tendencies where available, and relevant policy or documentation considerations. The content is written for a national audience and is intended to clarify when CPT code 95874 is used, why it may be reported as an add-on to chemodenervation procedures, and what operational documentation is typically associated with the service.
Data not available in the input for specific payor policies, associated taxonomies, and ICD-10 diagnoses.
Billing Code Overview
CPT code 95874 is an add-on electromyography guidance procedure used when a provider performs needle electromyography (EMG) to guide a chemodenervation injection. Chemodenervation involves injecting a neurotoxin (for example, ethyl alcohol or botulinum toxin) into nerves that supply muscles to reduce spasticity and treat other neurological disorders.
Service type: Image-guided or instrument-assisted injection guidance using needle EMG
Typical site of service: Outpatient procedure settings such as ambulatory surgical centers, hospital outpatient departments, or physician offices where chemodenervation injections are performed
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with chronic post-stroke spasticity of the right upper extremity presents to an outpatient neurology clinic for targeted chemodenervation. After evaluation, the treating physician plans focal injections of onabotulinumtoxinA into spastic forearm and wrist flexor muscles. Needle electromyography (EMG) guidance is used to confirm active motor points and localize injections for maximal effect. The clinical workflow includes pre-procedure informed consent and review of anticoagulation status, brief focused neurological and musculoskeletal exam to identify hyperactive muscles, selection of target muscles and doses, sterile preparation, needle EMG localization, chemodenervation injections, and post-injection monitoring for immediate adverse effects and counseling on expected onset and duration of effect. The procedure typically occurs in an ambulatory surgery center or outpatient clinic procedure room equipped for EMG and injection, staffed by a physician trained in neuromuscular procedures and an assistant or nurse for vital sign monitoring and documentation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician’s interpretation/service separate from a facility technical component if applicable. |
50 | Bilateral procedure | Use when identical chemodenervation with EMG guidance is performed on both sides during the same encounter and payer accepts bilateral reporting. |
51 | Multiple procedures | Use when additional distinct procedures are reported on the same day in addition to the primary service. |
52 | Reduced services | Use when the procedure is partially reduced or not completed as planned. |
53 | Discontinued procedure | Use when aborted due to extenuating circumstances prior to completion. |
59 | Distinct procedural service | Use to indicate a procedure that is distinct and separate from other procedures performed on the same day when bundling edits might apply. |
62 | Two surgeons | Use when two surgeons work together as co-surgeons for a procedure requiring their skill sets (rare for this procedure). |
76 | Repeat procedure by same physician | Use when the same physician repeats the procedure later the same day. |
78 | Unplanned return to the operating/procedural site by the same physician following initial procedure for a related problem on the same day | Use if an unexpected return occurs for a complication or additional treatment. |
80 | Assistant surgeon | Use when a surgical assistant is required and documented. |
59 | Distinct procedural service | Use to indicate independent services when NCCI edits would bundle procedures (duplicate entry for emphasis if payer requires distinct modifier). |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 2086S | Neurology | Neurologists commonly perform EMG-guided chemodenervation for spasticity management. |
| 2084P0800X | Physical Medicine & Rehabilitation | Physiatrists frequently perform targeted botulinum toxin injections with EMG guidance. |
| 208D00000X | Neuromusculoskeletal Medicine | Specialists in neuromusculoskeletal care may perform these procedures in outpatient settings. |
| 207RH0000X | Pain Management | Interventional pain physicians may perform chemodenervation for focal spasticity or dystonia. |
| 207L00000X | Family Medicine | Some family medicine physicians with procedural training perform outpatient injections with EMG guidance. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
G81.11 | Hemiplegia, dominant side | Common post-stroke motor impairment associated with spasticity targeted by chemodenervation. |
G81.21 | Spastic hemiplegia, left dominant | Specific coding for spastic hemiplegia guiding indication for focal toxin injections. |
G83.4 | Infantile cerebral palsy | Cerebral palsy frequently causes focal spasticity requiring serial chemodenervation treatments. |
G24.3 | Spasmodic torticollis | Focal dystonia amenable to EMG-guided botulinum toxin injections. |
M62.838 | Spasm of muscle, other site | General muscle spasm diagnosis that may be treated with targeted chemodenervation when focal and refractory. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
20552 | Injection(s); single or multiple trigger point(s), myofascial pain | May be performed for concurrent myofascial pain management in the same visit; distinct from chemodenervation and may require modifier to indicate separate service. |
64612 | Chemodenervation of one extremity; percutaneous injection of neurolytic agent (e.g., phenol, alcohol) | Alternative chemodenervation technique for neurolytic agents; represents a related approach when neurolysis rather than botulinum toxin is used. |
95886 | Needle electromyography, 1 extremity with or without related paraspinal areas, 1-2 muscles studied | Represents standalone diagnostic needle EMG; components of EMG guidance may overlap with the service described by 95874. |
99024 | Postoperative follow-up visit global fee period, minor surgery | Used for routine postoperative or post-procedure follow-up visits within global period when applicable. |
97162 | Physical therapy evaluation, moderate complexity | May be included in multidisciplinary care planning before or after chemodenervation for spasticity management. |